MétaCan
Menu
Back to cohort
Record W4386663667 · doi:10.54434/candj.75

Review: The Efficacy of Curcumin in Cognitive Impairment

2021· article· en· W4386663667 on OpenAlex

Why this work is in the frame

A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.

venuePublished in a venue whose home country is Canada.
no affNo Canadian affiliation: this work is invisible to an affiliation-only frame.
No Canadian affiliation. An affiliation-only frame, the usual design, would never have seen this work. It is one of the works that make the case for inverting the frame.

Bibliographic record

VenueCAND Journal · 2021
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicMedicinal Plants and Bioactive Compounds
Canadian institutionsnot available
Fundersnot available
KeywordsCurcuminCINAHLCognitive declineDementiaCognitionMedicinePlaceboInclusion and exclusion criteriaDiseaseMeta-analysisAdjunctive treatmentMEDLINEGerontologyAlternative medicinePsychological interventionPsychiatryPharmacologyInternal medicinePathology

Abstract

fetched live from OpenAlex

Background Dementia is a syndrome characterized by a progressive cognitive decline that can interfere with everyday function. The presence of inflammation is associated with the progression of cognitive decline. Treatment of inflammation-induced cognitive decline has been proposed through the use of anti-inflammatories. One intervention studied is curcumin, a compound extracted from the spice turmeric with anti-inflammatory properties. This paper reviews the efficacy of curcumin in cognitive decline.
 Purpose This review seeks to understand how effective curcumin is an intervention for optimizing cognition in older adults ages 55 and older compared to placebo. This study will benefit the naturopathic doctor investigating curcumin's current literature and its efficacy in treating cognitive decline.
 Methods A literature search was conducted in accordance with literature review methods. Using the keywords [curcumin OR turmeric] AND [Alzheimer's disease OR dementia], a preliminary search for relevant articles on this topic was conducted on MEDLINE, PubMed, CINAHL, Embase and Cochrane databases screened for article titles containing dementia, Alzheimer's disease and curcumin, and filtering for articles published from 2000 onward and in English.
 Results Six studies were found eligible after considering inclusion and exclusion criteria. Of these studies, four of them have shown positive cognition improvements, and two studies have shown no improvement in cognition.
 Implications Curcumin may have potential as an intervention for the treatment of cognitive decline. However, due to insufficient studies, more research is warranted to understand better if curcumin is beneficial as an adjunctive treatment for Alzheimer's disease.
 Key Messages
 
 Inflammation plays a potential role in Alzheimer's disease. Curcumin is a compound extracted from the spice turmeric and possesses anti-inflammatory properties.
 Curcumin may be a potential adjuvant in treating mild cognitive impairment, but likely not for those diagnosed with dementia.
 Future research on curcumin use is needed to better address and understand its efficacy on individuals living with mild cognitive impairment and dementia.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.281
Threshold uncertainty score0.121

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.018
GPT teacher head0.305
Teacher spread0.287 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it